The world has been facing the COVID-19 global pandemic for almost a year, but it finally feels like there is light at the end of the tunnel – vaccines. The Biden administration is currently pushing for a more accelerated vaccination rollout in the U.S., and the President recently suggested the nation could soon reach an average of 1.5 million shots a day. This push comes as many health experts call the initial vaccine rollout “flawed” and express concerns over the amount of Americans vaccinated thus far. As a healthcare PR agency working with clients across the industry, we are well-versed on the latest vaccine news and “hot takes” from industry executives and wanted to share what we have been hearing lately from our clients.  

COVID has had a huge impact on healthcare, and will continue to for years to come.  Some of the changes, like the ability to muster a massive response to a rapid influx of patients, are obvious, but others are more subtle and unexpected.  From my perspective, working primarily with technology companies seeking to help health systems, health plans and other stakeholders innovate and evolve, I have seen some very interesting changes in where healthcare decision-makers are shifting their attention and investing their money and resources.